Abstract
Stroke has multiple etiologies, but the underlying genes and pathways are largely unknown. We conducted a multiancestry genome-wide-association meta-analysis in 521,612 individuals (67,162 cases and 454,450 controls) and discovered 22 new stroke risk loci, bringing the total to 32. We further found shared genetic variation with related vascular traits, including blood pressure, cardiac traits, and venous thromboembolism, at individual loci (n = 18), and using genetic risk scores and linkage-disequilibrium-score regression. Several loci exhibited distinct association and pleiotropy patterns for etiological stroke subtypes. Eleven new susceptibility loci indicate mechanisms not previously implicated in stroke pathophysiology, with prioritization of risk variants and genes accomplished through bioinformatics analyses using extensive functional datasets. Stroke risk loci were significantly enriched in drug targets for antithrombotic therapy.
Original language | English |
---|---|
Pages (from-to) | 524-537 |
Number of pages | 14 |
Journal | Nature Genetics |
Volume | 50 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2018 |
Bibliographical note
Publisher Copyright:© 2018 The Author(s).
Funding
S. Gretarsdottir, G.T., U.T., and K.S. are all employees of deCODE Genetics/ Amgen, Inc. M.A.N. is an employee of Data Tecnica International. P.T.E. is the PI on a grant from Bayer HealthCare to the Broad Institute, focused on the genetics and therapeutics of atrial fibrillation. S.A.L. receives sponsored research support from Bayer HealthCare, Biotronik, and Boehringer Ingelheim, and has consulted for St. Jude Medical and Quest Diagnostics. E.I. is a scientific advisor for Precision Wellness, Cellink and Olink Proteomics for work unrelated to the present project. B.M.P. serves on the DSMB of a clinical trial funded by Zoll LifeCor and on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. The remaining authors have no disclosures.
Funders | Funder number |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | R01HL088521 |
National Heart, Lung, and Blood Institute (NHLBI) | |
Johnson and Johnson Pharmaceutical Research and Development | |
Yale University | |
St. Jude Medical Center | |
Boehringer-Ingelheim | |
Bayer HealthCare Pharmaceuticals Inc. | |
Biotronik Incorporated |
ASJC Scopus subject areas
- Genetics